Cargando…
Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area
BACKGROUND: Leishmania infantum and Dirofilaria immitis are among the most important canine vector-borne pathogens (CVBPs) of zoonotic concern in Europe. In endemic areas for both of these CVBPs, the use of systemic ectoparasiticides, such as afoxolaner (NexGard®; Boehringer Ingelheim Animal Health)...
Autores principales: | Panarese, Rossella, Iatta, Roberta, Mendoza-Roldan, Jairo Alfonso, Zatelli, Andrea, Beugnet, Frederic, Otranto, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323259/ https://www.ncbi.nlm.nih.gov/pubmed/34325730 http://dx.doi.org/10.1186/s13071-021-04883-3 |
Ejemplares similares
-
Afoxolaner (NexGard®) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae)
por: Alfonso Mendoza-Roldan, Jairo, et al.
Publicado: (2023) -
Treatment of canine sarcoptic mange with afoxolaner (NexGard(®)) and afoxolaner plus milbemycin oxime (NexGard Spectra(®)) chewable tablets: efficacy under field conditions in Portugal and Germany
por: Hampel, Verena, et al.
Publicado: (2018) -
Leishmania infantum and Dirofilaria immitis infections in Italy, 2009–2019: changing distribution patterns
por: Mendoza-Roldan, Jairo, et al.
Publicado: (2020) -
Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe
por: Lebon, Wilfried, et al.
Publicado: (2018) -
Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard(®)
por: Liebenberg, Julian, et al.
Publicado: (2017)